Examining the FDA's regulation of over-the-counter monograph drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Nineteenth Congress, first session, April 1, 2025.

Format:

Book

Government document

Author/Creator:

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.

Language:

English

Subjects (All):

Drugs, Nonprescription--Law and legislation--United States.

Drugs, Nonprescription.

User charges--United States.

User charges.

Genre:

Legislative hearings.

Physical Description:

vi, 168 pages : illustrations ; 24 cm

1 online resource (vi, 168 pages) : color illustrations.

Place of Publication:

Washington : U.S. Government Publishing Office, 2025.

Participant:

Hearing witnesses: Kevin Menzel, Member, Board of Directors, Consumer Healthcare Products Association, and President, Focus Consumer Healthcare; Douglas M. Troutman, Interim Co-Chief Executive Officer, American Cleaning Institute; Kim Wezik, Director of Advocacy, Melanoma Research Foundation; Scott Faber, Senior Vice President, Government Affairs, Environmental Working Group; Carl D'Ruiz, Senior Science, Advocacy, and Business Development Manager, DSM-Firmenich, and Former Chair, Personal Care Products Council.

Notes:

Redacted.

"Serial no. 119-14."

Includes bibliographical references.

Date of hearing: 2025-04-01.

Description based on online resource, PDF version; title from title page (GovInfo, viewed March 16, 2023).

In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).

Other Format:

Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining the FDA's regulation of over-the-counter monograph drugs

OCLC:

1535343191

Publisher Number:

60-082 (GPO jacket number)